Omalizumab, an anti-immunoglobulin E antibody: state of the art.
about
Shifting Focus in the Therapeutics of Immunobullous Disease.Omalizumab in children.Evolution of anti-IgE treatment.IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.Burden and distinctive character of allergic bronchopulmonary aspergillosis in India.Focusing the mechanism of action to dissect the different treatments of respiratory allergy.Omalizumab therapy for children and adolescents with severe allergic asthma.Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.Treating IgE-mediated diseases via targeting IgE-expressing B cells using an anti-CεmX antibody.Comparable actions of omalizumab on mast cells and basophils.Are allergic fungal rhinosinusitis and allergic bronchopulmonary aspergillosis lifelong conditions?Effect of anti-IgE in occupational asthma caused by exposure to low molecular weight agents.New approaches for identifying and testing potential new anti-asthma agents.Immunoglobulin G; structure and functional implications of different subclass modifications in initiation and resolution of allergy.Omalizumab for difficult-to-treat dermatological conditions: clinical and immunological features from a retrospective real-life experience.Eosinophils from Physiology to Disease: A Comprehensive Review.
P2860
Q33737974-09BCB2C4-8519-4147-8B16-9795FBBD05BCQ34604574-694D9600-09A8-461D-AC9C-E4F0DAF26F23Q36870053-F99AE5B0-EDD0-4CD0-B6C0-984B58BD52F2Q37554168-25A1483E-FFE5-464F-85C0-FCECD78A1FA3Q38221676-ADE37CF3-D859-4DBC-BA3C-50C740C89227Q38542919-3B899008-9D34-4DE1-9BCC-4701D7F018E1Q38574776-C98A3A74-384E-4842-9B96-343D1B0D3FD5Q38754492-A10AAB0B-D522-4493-B5C5-21EC4C6EF769Q38811111-8BF661F2-CD8D-486F-A681-C986A43A5216Q38824255-6D363D89-14FA-488C-B697-2401BB6B29EAQ38948097-5D96989C-BE07-4FF7-BF43-F81106808045Q47218290-9DA51DFE-1778-4A7E-89F5-A0D606E7E65BQ47873103-08651E93-1227-449F-AAE5-EBE4E6C7334AQ48256010-325C62EA-1577-421F-A16C-D78466C9E981Q52976551-0DB2C224-FC77-427B-AE41-A4FAD97DFBC0Q55311740-EF04C3EA-0911-49A1-A9AD-FAAEEB4B83CA
P2860
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@ast
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@en
type
label
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@ast
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@en
prefLabel
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@ast
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@en
P2093
P2860
P356
P1476
Omalizumab, an anti-immunoglobulin E antibody: state of the art.
@en
P2093
Chiara Formigoni
Gian Galeazzo Riario-Sforza
Marina Mauro
Marina Russello
P2860
P304
P356
10.2147/DDDT.S49409
P407
P577
2014-02-07T00:00:00Z